NCT03239366 - A Study to Evaluate the Effect of BioK+ 50B® on Glycemic Control in a Type 2 Diabetes Population | Biotech Hunter

Enrollment

130

Participants

Timeline

Start Date

September 6, 2017

Primary Completion Date

February 28, 2019

Study Completion Date

June 30, 2019

Conditions

Type2 Diabetes

Interventions

OTHER

BioK+ 100% probiotic

The active BioK+ product will include the 3 strains of Lactobacillus: L. acidophilus CL1285®, L. casei LBC80R® and L. rhamnosus CLR2®, representing the bacteria found in Bio-K+ probiotic capsules 50B®;

OTHER

Placebo

The placebo product will NOT include the 3 strains of Lactobacillus: L. acidophilus CL1285®, L. casei LBC80R® and L. rhamnosus CLR2®, representing the bacteria found in Bio-K+ probiotic capsules 50B®;

Trial Locations (1)

H1T1C8

RECRUITING

Montreal Heart Institute, Montreal